The intensive lipid modulation group significantly reduced the incidence of perioperative major adverse cardiac events especially asymptomatic myocardial infarction , and the inhibition of the inflammatory response may be one of the protective mechanisms , which still needs to be further confirmed by large multicenter randomized controlled clinical trials .